Cellebrite DI Financial Ratios
NASDAQ: CLBTTechnologyComputer Software: Prepackaged SoftwareUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cellebrite DI ratio analysis
Cellebrite DI earned a net margin of 16.5% in FY 2025, up from -70.5% a year earlier. Gross margin was 84.2% compared with a median of 82.0% over the prior 6 years. Return on equity reached 16.2%, meaning Cellebrite DI generated 0.16 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, CLBT traded at 57.5 times earnings; across the 3 fiscal years shown, its year-end P/E ranged from 7.4 to 57.5, with a median of 18.2. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Cellebrite DI financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 57.55 | — | — | 7.39 | 18.23 | — | — |
| Price / sales | 9.06 | 11.54 | 5.07 | 2.94 | 4.69 | 6.68 | — |
| Price / book | 8.90 | 13.78 | 48.13 | 10.78 | — | 20.41 | — |
| Gross margin | 84.2% | 84.4% | 83.6% | 81.3% | 82.7% | 80.6% | 79.2% |
| Operating margin | 14.0% | 14.2% | 10.2% | 0.4% | 5.6% | 4.7% | -0.9% |
| Net margin | 16.5% | -70.5% | -24.9% | 44.6% | 29.0% | 3.0% | -1.1% |
| Free cash flow margin | 33.7% | 30.8% | 29.8% | 5.1% | 12.6% | 31.0% | 5.8% |
| Return on equity (ROE) | 16.2% | -84.2% | -237.1% | 163.5% | — | 9.1% | -3.2% |
| Return on assets (ROA) | 8.3% | -41.0% | -15.2% | 30.0% | 21.0% | 1.6% | — |
| Current ratio | 1.56 | 1.92 | 1.66 | 1.42 | 1.46 | 2.03 | — |
| Revenue growth | 18.6% | 23.4% | 20.1% | 9.9% | 26.3% | 13.4% | — |
| EPS growth | — | — | -172.9% | 34.1% | — | — | — |